Some content of this application is unavailable at the moment.
If this situation persists, please contact us atFeedback&Contact
1. (WO2018186420) CELL POPULATION INCLUDING MESENCHYMAL STEM CELLS, PRODUCTION METHOD THEREFOR, MESENCHYMAL STEM CELLS, AND PHARMACEUTICAL COMPOSITION
Latest bibliographic data on file with the International BureauSubmit observation

Pub. No.: WO/2018/186420 International Application No.: PCT/JP2018/014325
Publication Date: 11.10.2018 International Filing Date: 03.04.2018
IPC:
C12N 5/0775 (2010.01) ,A61K 35/28 (2015.01) ,A61L 27/38 (2006.01) ,A61P 37/00 (2006.01) ,C12N 5/077 (2010.01)
C CHEMISTRY; METALLURGY
12
BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
N
MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
5
Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
07
Animal cells or tissues
071
Vertebrate cells or tissues, e.g. human cells or tissues
077
Mesenchymal cells, e.g. bone cells, cartilage cells, marrow stromal cells, fat cells or muscle cells
0775
Mesenchymal stem cells; Adipose-tissue derived stem cells
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
35
Medicinal preparations containing material or reaction products thereof with undetermined constitution
12
Materials from mammals or birds
28
Marrow; Spleen
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
L
METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION, OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES
27
Materials for prostheses or for coating prostheses
36
containing ingredients of undetermined constitution or reaction products thereof
38
Animal cells
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
P
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
37
Drugs for immunological or allergic disorders
C CHEMISTRY; METALLURGY
12
BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
N
MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
5
Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
07
Animal cells or tissues
071
Vertebrate cells or tissues, e.g. human cells or tissues
077
Mesenchymal cells, e.g. bone cells, cartilage cells, marrow stromal cells, fat cells or muscle cells
Applicants:
株式会社カネカ KANEKA CORPORATION [JP/JP]; 大阪府大阪市北区中之島二丁目3番18号 3-18, Nakanoshima 2-chome, Kita-ku, Osaka-shi, Osaka 5308288, JP
Inventors:
稲生 渓太 INO Keita; JP
喜田 悠太 KITA Yuta; JP
Agent:
特許業務法人平木国際特許事務所 HIRAKI & ASSOCIATES; 東京都港区愛宕二丁目5-1 愛宕グリーンヒルズMORIタワー32階 Atago Green Hills MORI Tower 32F, 5-1, Atago 2-chome, Minato-ku, Tokyo 1056232, JP
Priority Data:
2017-07398303.04.2017JP
Title (EN) CELL POPULATION INCLUDING MESENCHYMAL STEM CELLS, PRODUCTION METHOD THEREFOR, MESENCHYMAL STEM CELLS, AND PHARMACEUTICAL COMPOSITION
(FR) POPULATION CELLULAIRE CONTENANT DES CELLULES SOUCHES MÉSENCHYMATEUSES AINSI QUE PROCÉDÉ DE FABRICATION DE CELLE-CI, CELLULES SOUCHES MÉSENCHYMATEUSES, ET COMPOSITION PHARMACEUTIQUE
(JA) 間葉系幹細胞を含む細胞集団とその製造方法、間葉系幹細胞及び医薬組成物
Abstract:
(EN) The present invention addresses the problem of providing a cell population which includes mesenchymal stem cells having a strong immunosuppressive effect, a production method therefor, mesenchymal stem cells having a strong immunosuppressive effect, and a pharmaceutical composition which includes the cell population. The present invention provides a production method for a cell population which includes mesenchymal stem cells, wherein the production method involves obtaining a cell population having the following cell characteristics indicated in (a) and (b): (a) the ratio of mesenchymal stem cells which are positive for CD97 in the cell population is 30% or higher, and (b) the cell population includes mesenchymal stem cells which are positive for CD358.
(FR) L’invention a pour objet de fournir une population cellulaire contenant des cellules souches mésenchymateuses présentant une immunosuppression élevée, un procédé de fabrication de cette population cellulaire, des cellules souches mésenchymateuses présentant une immunosuppression élevée, et une composition pharmaceutique contenant ladite population cellulaire. Plus précisément, l’invention concerne un procédé de fabrication de population cellulaire contenant des cellules souches mésenchymateuses, qui inclut l’acquisition d’une population cellulaire présentant les caractéristiques cellulaires (a) et (b) suivantes. Ainsi, le procédé de l’invention est tel que (a) la proportion de cellules souches mésenchymateuses présentant une valeur CD97 positive dans ladite population cellulaire, est supérieure ou égale à 30%, et (b) ladite population cellulaire contient des cellules souches mésenchymateuses présentant une valeur CD358 positive.
(JA) 本発明の課題は、高い免疫抑制作用を示す間葉系幹細胞を含む細胞集団及びその製造方法、高い免疫抑制作用を示す間葉系幹細胞、並びに上記細胞集団を含む医薬組成物を提供することである。本発明によれば、間葉系幹細胞を含む細胞集団の製造方法であって、以下に示す(a)及び(b)の細胞特性を有する細胞集団を取得することを含む、製造方法:(a)前記細胞集団において、CD97が陽性を呈する間葉系幹細胞の比率が30%以上であり、かつ(b)前記細胞集団が、CD358が陽性を呈する間葉系幹細胞を含む、が提供される。
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JO, JP, KE, KG, KH, KN, KP, KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW
African Regional Intellectual Property Organization (ARIPO) (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, RU, TJ, TM)
European Patent Office (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG)
Publication Language: Japanese (JA)
Filing Language: Japanese (JA)